Search - tctmd.com

Displaying 1 - 20 of 95

Sort: Relevancy | Date

News Daily News

Eye Condition a ‘Very Rare’ Side Effect of Semaglutide, EMA Says

Todd Neale

June 06, 2025

News Conference News SCAI 2025

When Early Cardiogenic Shock Isn’t Dealt With, Outcomes Can Suffer

L.A. McKeown

May 09, 2025

News Daily News

FDA Drops REMS Requirement for Antihypertensive Aprocitentan

Michael O'Riordan

April 09, 2025

News Opinion Editor's Corner

Solutions to TCTMD’s 2024 Cardiology Crossword Challenge

Shelley Wood

January 08, 2025

News Daily News

Coronary CTA Reimbursement for US Hospitals to Double in 2025

Yael L. Maxwell

November 08, 2024

News Daily News

Obstacles Abound for Treating Severe BP: Some Clues for Care Lie in EHRs

Caitlin E. Cox

August 08, 2024

News Daily News

EMA: No Evidence of Link Between GLP-1 Receptor Agonists and Suicidal Thoughts

Todd Neale

April 12, 2024

News Conference News CRT 2024

SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI

L.A. McKeown

March 15, 2024

News Conference News THT 2024

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

Michael O'Riordan

March 11, 2024

News Daily News

FDA: No Signs of Link Between GLP-1s and Suicidal Thoughts, Actions

Todd Neale

January 12, 2024

News Opinion Editor's Corner

Solutions to TCTMD’s 2023 Cardiology Crossword Challenge

Shelley Wood

January 08, 2024

News Daily News

Biden White House Delays Decision on Menthol Ban

Michael O'Riordan

December 07, 2023

News Daily News

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

L.A. McKeown

November 20, 2023

News Conference News AHA 2023

Automatic Scripts, Pharmacist Phone Calls Boost Statin Prescribing

Shelley Wood

November 14, 2023

News Daily News

GLP-1 Meds Linked to 265 Reports to FDA of Suicidal Ideation: Reuters

Shelley Wood

September 28, 2023

News Daily News

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

L.A. McKeown

September 18, 2023

News Daily News

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

Michael O'Riordan

September 15, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2023

Shelley Wood

July 31, 2023

News Daily News

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

L.A. McKeown

July 11, 2023

News Daily News

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Michael O'Riordan

June 23, 2023

Advertisement

Eye Condition a ‘Very Rare’ Side Effect of Semaglutide, EMA Says

When Early Cardiogenic Shock Isn’t Dealt With, Outcomes Can Suffer

FDA Drops REMS Requirement for Antihypertensive Aprocitentan

Solutions to TCTMD’s 2024 Cardiology Crossword Challenge

Coronary CTA Reimbursement for US Hospitals to Double in 2025

Obstacles Abound for Treating Severe BP: Some Clues for Care Lie in EHRs

EMA: No Evidence of Link Between GLP-1 Receptor Agonists and Suicidal Thoughts

SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

FDA: No Signs of Link Between GLP-1s and Suicidal Thoughts, Actions

Solutions to TCTMD’s 2023 Cardiology Crossword Challenge

Biden White House Delays Decision on Menthol Ban

Asundexian’s Lack of Efficacy Sinks OCEANIC-AF

Automatic Scripts, Pharmacist Phone Calls Boost Statin Prescribing

GLP-1 Meds Linked to 265 Reports to FDA of Suicidal Ideation: Reuters

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

TCTMD’s Top 10 Most Popular Stories for July 2023

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content